William B. III Stilley

ADIL

CHIEF EXECUTIVE OFFICER · ADIAL PHARMACEUTICALS, INC. · CIK 0001718069

FILING MIX · LIFETIME94%/6%

BUYS

SELLS

TOTAL VALUE

$87.6K

COMPANIES

ACTIVE SINCE

Mar 2020

HOLDINGS NOW

1,269,779

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

4 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by William B. III Stilley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	4	+25.00%	-2.62%	-0.58%	-2.04%	-3.06%	—
14d	4	+50.00%	-1.69%	+4.92%	-6.61%	-8.81%	—
30d	4	+50.00%	+3.38%	+7.76%	-4.38%	-3.63%	—
60d	4	+50.00%	+1.54%	+6.76%	-5.21%	-4.71%	—
90d	4	+50.00%	-5.40%	+8.61%	-14.01%	-12.36%	—
180d	4	+50.00%	-25.18%	+10.72%	-35.89%	-35.37%	—
1y	4	+50.00%	-0.90%	+22.92%	-23.82%	-23.22%	—
2y	4	+50.00%	-18.02%	+42.87%	-60.88%	-60.94%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

ADIL · 1,261,779 shares · as of May 23, 2023

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

FLOW · 15 buys / 1 sellsCOVERAGE · 14 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	50,000	—	—	50,000	May 23, 2023	May 25, 2023 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	240,800	—	—	1,261,779	May 23, 2023	May 25, 2023 ↗	View →
ALBT AVALON GLOBOCARE CORP.	PURCHASEGRANT Stock grant	8,000	—	—	8,000	Jan 1, 2023	Mar 8, 2023 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	SALE	166,667	—	—	1,020,979	Dec 30, 2022	Jan 3, 2023 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	100,000	—	—	100,000	Aug 22, 2022	Aug 23, 2022 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	250,000	—	—	1,187,646	Feb 23, 2022	Feb 24, 2022 ↗	View →
ALBT AVALON GLOBOCARE CORP.	PURCHASEGRANT Stock grant	8,000	—	—	8,000	Jan 1, 2022	Mar 8, 2023 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASE Chief Executive Officer	10,600	$2.75	$29.2K	937,646	Nov 30, 2021	Dec 1, 2021 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASE Chief Executive Officer	10,000	$2.59	$25.9K	927,046	Nov 29, 2021	Dec 1, 2021 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	250,000	—	—	250,000	Feb 8, 2021	Feb 10, 2021 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	201,109	—	—	917,046	Jan 26, 2021	Jan 28, 2021 ↗	View →
ALBT AVALON GLOBOCARE CORP.	PURCHASEGRANT Stock grant	8,000	—	—	8,000	Jan 1, 2021	Mar 8, 2023 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASE Chief Executive Officer	12,652	$1.47	$18.6K	715,937	Mar 26, 2020	Mar 27, 2020 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASE Chief Executive Officer	12,348	$1.13	$14.0K	703,285	Mar 25, 2020	Mar 27, 2020 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	54,167	—	—	690,937	Mar 3, 2020	Mar 5, 2020 ↗	View →
ADIL ADIAL PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	460,000	—	—	460,000	Mar 3, 2020	Mar 5, 2020 ↗	View →

Other insiders · ADIL

Loading peer insiders…

About this filer

CIK 0001718069

ROLE

Chief Executive Officer

PRIMARY

ADIL

COMPANIES

ACTIVE SINCE

Mar 2020

MARKETPEEL · /INSIDER/0001718069DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

William B. III Stilley

The morning brief, before the bell.